FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1148549008: Tepotinib hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4550516012 Tepotinib hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module
4550517015 Tepotinib hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tepotinib hydrochloride Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is modification of Tepotinib true Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Has disposition Protein-tyrosine kinase inhibitor false Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is a Piperidine true Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is a Substance with protein-tyrosine kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is a Substance with mesenchymal epithelial transition inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Has disposition Mesenchymal epithelial transition inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Tepotinib hydrochloride Inferred relationship Existential restriction modifier 1
Tepmetko 225mg tablets (Merck Serono Ltd) 60 tablet Has specific active ingredient True Tepotinib hydrochloride Inferred relationship Existential restriction modifier
Tepmetko 225mg tablets (Merck Serono Ltd) Has specific active ingredient True Tepotinib hydrochloride Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has specific active ingredient True Tepotinib hydrochloride Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets Has specific active ingredient True Tepotinib hydrochloride Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start